Zoonotic & Vector-Borne Diseases

>

Latest News

New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease
New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease

May 14th 2025

A small percentage of people who contract the tick-borne illness have lingering symptoms and health issues after the acute infection has been treated, but there are no FDA-approved therapies to deal with prolonged symptoms. A new report looks to address this issue.

FDA and CDC Recommend Pause on Chikungunya Vaccine IXCHIQ for Adults 65 and Older
FDA and CDC Recommend Pause on Chikungunya Vaccine IXCHIQ for Adults 65 and Older

May 12th 2025

Clinical Strategies for Tick Season: Lyme Prevention and Next-Gen Diagnostics
Clinical Strategies for Tick Season: Lyme Prevention and Next-Gen Diagnostics

May 9th 2025

Single, Low Dose Primaquine Safely Blocks Malaria Transmission
Single, Low Dose Primaquine Safely Blocks Malaria Transmission

May 6th 2025

Pneumonia Antibiotic Cures Lyme Disease at Doses 100 Times Lower Than Standard Treatment
Pneumonia Antibiotic Cures Lyme Disease at Doses 100 Times Lower Than Standard Treatment

April 29th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.